✦ LIBER ✦

Outcome After Failure of Second Generation Tyrosine Kinase Inhibitors Treatment As First-line Therapy for Patients With Chronic Myeloid Leukemia

✍ Scribed by Eghtedar, Alireza; Kantarjian, Hagop; Jabbour, Elias; O'Brien, Susan; Burton, Elizabeth; Garcia-Manero, Guillermo; Verstovsek, Srdan; Ravandi, Farhad; Borthakur, Gautam; Konopleva, Marina; Quintas-Cardama, Alfonso; Cortes, Jorge

Book ID: 120512464
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 439 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.02.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of Treatment of Chronic Myeloid

Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure

✍ A. Megan Cornelison; Hagop Kantarjian; Jorge Cortes; Elias Jabbour 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 414 KB

Survival outcomes for clonal evolution i

Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy

✍ Dushyant Verma; Hagop Kantarjian; Jianqin Shan; Susan O'Brien; Zeev Estrov; Guil 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB

Front-Line Therapy With Second-Generatio

Front-Line Therapy With Second-Generation Tyrosine Kinase Inhibitors in Patients With Early Chronic Phase Chronic Myeloid Leukemia: What Is the Optimal Response?

✍ Jabbour, E.; Kantarjian, H. M.; O'Brien, S.; Shan, J.; Quintas-Cardama, A.; Garc 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 126 KB

Evolving treatment strategies for patien

Evolving treatment strategies for patients newly diagnosed with chronic myeloid leukemia: the role of second-generation BCR–ABL inhibitors as first-line therapy

✍ Shami, P J; Deininger, M 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 421 KB

Second-line Therapy and Beyond Resistanc

Second-line Therapy and Beyond Resistance for the Treatment of Patients With Chronic Myeloid Leukemia Post Imatinib Failure

✍ Jabbour, Elias; Cortés, Jorge E.; Kantarjian, Hagop 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 174 KB

Has the time for first-line treatment wi

Has the time for first-line treatment with second generation tyrosine kinase inhibitors in patients with chronic myelogenous leukemia already come? Systematic review and meta-analysis

✍ Gurion, R.; Gafter-Gvili, A.; Vidal, L.; Leader, A.; Ram, R.; Shacham-Abulafia, 📂 Article 📅 2012 🏛 Ferrata Storti Foundation 🌐 Italian ⚖ 915 KB